Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies
Authors
Keywords
-
Journal
Microbiology Spectrum
Volume -, Issue -, Pages -
Publisher
American Society for Microbiology
Online
2021-09-01
DOI
10.1128/spectrum.00087-21
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evolution of antibody immunity to SARS-CoV-2
- (2021) Christian Gaebler et al. NATURE
- T cell response to SARS-CoV-2 infection in humans: A systematic review
- (2021) Madhumita Shrotri et al. PLoS One
- COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses
- (2021) Agnes Bonifacius et al. IMMUNITY
- A New SARS CoV-2 Dual Purpose Serology Test: Highly Accurate Infection Tracing and Neutralizing Antibody Response Detection
- (2021) Sean C. Taylor et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Lasting antibody and T cell responses to SARS-CoV-2 in COVID-19 patients three months after infection
- (2021) Xiao-Lin Jiang et al. Nature Communications
- Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection
- (2021) Raymond A. Harvey et al. JAMA Internal Medicine
- Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study
- (2021) Christian Holm Hansen et al. LANCET
- SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
- (2021) Victoria Jane Hall et al. LANCET
- IgV somatic mutation of human anti–SARS-CoV-2 monoclonal antibodies governs neutralization and breadth of reactivity
- (2021) Mayara Garcia de Mattos Barbosa et al. JCI Insight
- SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity
- (2021) Stine SF Nielsen et al. EBioMedicine
- Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers
- (2020) Roger Chou et al. ANNALS OF INTERNAL MEDICINE
- Mild or Moderate Covid-19
- (2020) Rajesh T. Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covid-19: PHE upgrades PPE advice for all patient contacts with risk of infection
- (2020) Anna Sayburn BMJ-British Medical Journal
- SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
- (2020) Nina Le Bert et al. NATURE
- Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study
- (2020) Long H Nguyen et al. Lancet Public Health
- Accuracy of serological testing for SARS‐CoV‐2 antibodies: first results of a large mixed‐method evaluation study
- (2020) D. Brigger et al. ALLERGY
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
- (2020) Sheila F. Lumley et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now